(UHS) Universal Health - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9139031002
UHS: Hospitals, Healthcare, Insurance, Management, Services
Universal Health Services, Inc. (NYSE: UHS) stands as a prominent player in the healthcare sector, operating a diverse network of acute care hospitals and behavioral health facilities across the United States. Established in 1978 and headquartered in King of Prussia, Pennsylvania, UHS has carved out a significant presence in the industry through its dual focus on acute care and behavioral health services.
The companys operational framework is divided into two primary segments: Acute Care Hospital Services and Behavioral Health Care Services. Under these umbrellas, UHS offers a comprehensive array of medical services, including general and specialty surgeries, internal medicine, obstetrics, emergency care, and oncology. Additionally, they provide diagnostic imaging, coronary care, and pediatric services, underscoring their commitment to holistic patient care.
UHS extends its reach beyond direct patient care by offering commercial health insurance services and a suite of management support functions. These include central purchasing, information systems, facilities planning, physician recruitment, and marketing. Such diversification not only enhances operational efficiency but also positions UHS as a multifaceted healthcare provider capable of navigating the complexities of the modern healthcare landscape.
From a financial perspective, UHS presents an intriguing profile for investors. With a market capitalization of approximately $12.5 billion, the company demonstrates substantial scale. The trailing P/E ratio of 12.61 and a forward P/E of 10.53 suggest a balanced valuation, potentially indicating stability and growth prospects. The price-to-book ratio of 1.87 and a price-to-sales ratio of 0.81 further highlight UHSs financial health and operational efficiency.
For fund managers and investors, UHSs strategic diversification into behavioral health and its robust management infrastructure are key strengths. These elements not only mitigate risks associated with industry fluctuations but also position the company to capitalize on growing demand for mental health services. UHSs balanced financial metrics and diversified service offerings make it a compelling consideration for those seeking exposure to the healthcare sector.
Additional Sources for UHS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
UHS Stock Overview
Market Cap in USD | 12,268m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 1990-03-26 |
UHS Stock Ratings
Growth Rating | 41.6 |
Fundamental | 68.9 |
Dividend Rating | 34.6 |
Rel. Strength | 14.9 |
Analysts | 3.83/5 |
Fair Price Momentum | 163.59 USD |
Fair Price DCF | 426.30 USD |
UHS Dividends
Dividend Yield 12m | 0.44% |
Yield on Cost 5y | 0.80% |
Annual Growth 5y | 31.95% |
Payout Consistency | 56.8% |
UHS Growth Ratios
Growth Correlation 3m | -52.5% |
Growth Correlation 12m | -7.9% |
Growth Correlation 5y | 68.7% |
CAGR 5y | 11.73% |
CAGR/Max DD 5y | 0.26 |
Sharpe Ratio 12m | 1.52 |
Alpha | 8.67 |
Beta | 0.536 |
Volatility | 29.20% |
Current Volume | 0k |
Average Volume 20d | 806.3k |
As of April 19, 2025, the stock is trading at USD 174.80 with a total of 0 shares traded.
Over the past week, the price has changed by -0.35%, over one month by -0.87%, over three months by -7.30% and over the past year by +14.23%.
Yes, based on ValueRay Fundamental Analyses, Universal Health (NYSE:UHS) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 68.90 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UHS as of April 2025 is 163.59. This means that UHS is currently overvalued and has a potential downside of -6.41%.
Universal Health has received a consensus analysts rating of 3.83. Therefor, it is recommend to buy UHS.
- Strong Buy: 7
- Buy: 1
- Hold: 10
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, UHS Universal Health will be worth about 176.7 in April 2026. The stock is currently trading at 174.80. This means that the stock has a potential upside of +1.08%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 228.7 | 30.8% |
Analysts Target Price | 238.2 | 36.3% |
ValueRay Target Price | 176.7 | 1.1% |